Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Blog
Podcast
Product Guide
Career Quest
Clinical Trials
Blog Post
Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults with Generalized Myasthenia Gravis (gMG)
By
Sujatha Gurunathan
|
March 9, 2023
Blog Post
What About My Disease? Why a New Treatment for One Neuromuscular Disease Is Good News for All
By
Cheryl Alkon
|
February 27, 2023
Featured Article
Q&A: Understanding Congenital Muscular Dystrophy
By
MDA Staff
|
February 16, 2023
Featured Article
MOVR Data Hub Aims to Improve Research and Care
By
Amy Bernstein
|
February 16, 2023
Featured Article
Q&A: Understanding Bethlem Myopathy
By
MDA Staff
|
November 18, 2022
Featured Article
3 Steps to Find Reliable Information on Neuromuscular Disease Research
By
Amy Bernstein
|
November 18, 2022
Blog Post
MDA Advocates Returned to Capitol Hill (Virtually)
By
Mark Fisher
|
October 25, 2022
Blog Post
Muscular Dystrophy Association Announces 70 Research Grants Totaling Over $17 Million
By
MDA Staff
|
September 19, 2022
Featured Article
Q&A on Facioscapulohumeral Muscular Dystrophy
By
MDA Staff
|
August 23, 2022
Blog Post
Clinical Trial Alert: Phase 3 Study of IgPro20 in Adults with Dermatomyositis
By
Sujatha Gurunathan
|
August 17, 2022
« Previous
1
…
3
4
5
6
7
…
19
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset